Abbott Vascular
3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
http://www.abbottvascular.com
Product Categories
Embolic Protection Devices, Stents, Stents Drug Eluting, Vascular Closure Devices, Stents Carotid, Stents Peripheral, Stents Bare Metal

Related Content

Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
News | Stents Bioresorbable
Late-breaking Data Show Esprit BTK Drug-eluting Resorbable Scaffold Reduces Chronic Limb-threatening Ischemia Progression Compared to the Standard of Care

October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK ...

Home October 30, 2023
arrow
New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US
News | Structural Heart
Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

Home October 26, 2023
arrow
The global interventional cardiology device market is driven by the number of procedures performed across the globe
Feature | Cardiovascular Business| By Emily Gilbert and Kamran Zamanian, PhD
The New Interventional Cardiology Market

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

Home September 12, 2023
arrow
Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement
News | Optical Coherence Tomography (OCT)
Abbott Unveils Late-breaking Data Showing Intravascular Imaging Via OCT can Improve Stent Procedural Outcomes, Especially in Complex Cases

August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...

Home August 29, 2023
arrow
The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
News | Heart Valve Technology
FDA Issues Update on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

July 31, 2023 — Today, the U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 ...

Home July 31, 2023
arrow
Rapid adoption of wireless cardiac monitoring devices and continuous advancements in remote monitoring technology are generating significant business opportunities for companies in the cardiovascular diagnostic and monitoring devices market
Feature | Implantable Cardiac Monitor (ICM)
Cardiovascular Diagnostic and Monitoring Devices Market to Cross $29B by 2031

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...

Home June 13, 2023
arrow
MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients
News | Heart Failure
European Study Finds the Abbott Cardiomems Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure ...

Home May 26, 2023
arrow
Gregg W. Stone, MD, Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology), and Population Health Science and Policy, at Icahn Mount Sinai
News | Stents Drug Eluting
Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients

May 25, 2023 — First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic ...

Home May 25, 2023
arrow
Abbott's AVEIR DR i2i IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker
News | Pacemakers
Abbott Unveils Late-breaking Data Showing the World's First Dual-chamber Leadless Pacemaker Study Met All Three Primary Endpoints

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...

Home May 25, 2023
arrow
global collaboration between medical technology leaders Abbott and Stereotaxis
News | Robotic Systems
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

May 24, 2023 — Stereotaxis announced a global collaboration with Abbott to integrate Abbott’s EnSite X EP System with ...

Home May 24, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now